Epizyme

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Epizyme and buy or sell other stocks, ETFs, and their options commission-free!

About EPZM

Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. 

CEO
Grant C. Bogle, MBA
CEOGrant C. Bogle, MBA
Employees
—
Employees—
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2007
Founded2007
Employees
—
Employees—

EPZM Key Statistics

Market cap
247.44M
Market cap247.44M
Price-Earnings ratio
-0.85
Price-Earnings ratio-0.85
Dividend yield
—
Dividend yield—
Average volume
4.24M
Average volume4.24M
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$5.80
52 Week high$5.80
52 Week low
$0.411
52 Week low$0.411

People also own

Based on the portfolios of people who own EPZM. This list is generated using Robinhood data, and it’s not a recommendation.
Nikola
Aurora Cannabis
Workhorse
Inovio
Tilray Brands
Virgin Galactic Holdings
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.